glp-1 alcohol Anti-Obesity Rx and and Substance Use Disorders GLP-1s Hold Promise as Treatment

Tirzepatide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 5 days (120 hours) Peak concentration: 8 to 72 hours after injection Recommended timing approach: The shorter half-life compared to semaglutide means the end-of-week trough is more noticeable

LegitScript tackles the sale of problematic healthcare products as well as more than 60 other high-risk categories including counterfeits, weapons, and online gambling with a multi-pronged approach that employs big data, AI-powered technology, and human expertise

That comparison can be misleading because these are fundamentally different product categories

A poll released Friday by KFF found that about 1 in 8 adults say they are currently taking a GLP-1 drug to treat a chronic disease, for weight loss or both an increase of 6% since May 2024